Published in Nature · View the paper (DOI)
Researchers from Vanderbilt University Medical Center have identified the cardiac antigen α-myosin as the mechanism for immunotherapy-related myocarditis, a rare but deadly complication affecting less than 1% of patients. The discovery sets the framework to identify biomarkers and develop strategies to tolerate immunotherapy in at-risk...
Coverage from 2 institutions